Zilebesiran in combination with a diuretic in patients with uncontrolled hypertension: a subgroup analysis from the Phase 2 KARDIA-3 trial

zilebesiran (ALN-AGT) - Alnylam, Roche

N Pagidipati1; M Weber2; M Saxena3; B Williams4; SG Goodman5; Z Xiang6; S Daga7; M Bengus8; I Bahn6; A Havasi6; CB Granger1

May 11, 2026